CT
REGN icon

Chicago Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Chicago Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
562
+259
+85% +$176K 0.05% 297
2026
Q1 		$234K Buy
+303
New +$232K 0.04% 343
2022
Q1 		– Sell
-1,078
Closed -$680K – 351
2021
Q4 		$680K Hold
1,078
– – 0.14% 168
2021
Q3 		$652K Buy
1,078
+95
+10% +$59K 0.14% 166
2021
Q2 		$549K Buy
+983
New +$498K 0.13% 170

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Chicago Trust's REGN Position: Q2 2026 in Review

Chicago Trust increased its Regeneron Pharmaceuticals (REGN) stake by 85% in Q2 2026, buying an estimated $176K and bringing the position to 562 shares worth $350K. The position accounts for 0.05% of the portfolio, ranked #297.

Chicago Trust first reported a position in REGN in Q2 2021 and has held it in 5 quarters since. The position peaked at $680K in Q4 2021. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Chicago Trust held 562 shares of Regeneron Pharmaceuticals worth $350K as of Q2 2026.
  • Chicago Trust bought 259 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $176K.
  • Regeneron Pharmaceuticals made up 0.05% of Chicago Trust's portfolio in Q2 2026, its #297 holding.
  • Chicago Trust first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
  • Chicago Trust's Regeneron Pharmaceuticals position peaked at $680K in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.